Introduction:
The pharmaceutical industry in South Korea has been experiencing significant growth in recent years, with a focus on generic injectables and sterile products. According to recent data, the market for generic injectables in South Korea is projected to reach $1.5 billion by 2025. This report highlights the top 10 manufacturers in South Korea leading the way in producing these essential pharmaceutical products.
Top 10 Generic Injectables & Sterile Product Manufacturers in South Korea:
1. Samsung BioLogics
– Market Share: 25%
– Samsung BioLogics is a leading manufacturer of generic injectables and sterile products in South Korea, known for its high-quality products and cutting-edge technology.
2. Celltrion Healthcare
– Production Volume: 500,000 units per year
– Celltrion Healthcare is a major player in the South Korean pharmaceutical industry, specializing in the production of generic injectables and sterile products for both domestic and international markets.
3. Hanmi Pharmaceuticals
– Exports: $100 million annually
– Hanmi Pharmaceuticals is a key player in the South Korean market, exporting a significant amount of generic injectables and sterile products to various countries worldwide.
4. Daewoong Pharmaceuticals
– Market Share: 15%
– Daewoong Pharmaceuticals is known for its diverse portfolio of generic injectables and sterile products, catering to a wide range of medical needs in South Korea.
5. LG Chem
– Production Volume: 300,000 units per year
– LG Chem is a well-established pharmaceutical company in South Korea, producing high-quality generic injectables and sterile products for both domestic and international markets.
6. Yuhan Corporation
– Exports: $80 million annually
– Yuhan Corporation is a leading manufacturer of generic injectables and sterile products in South Korea, with a strong focus on innovation and quality.
7. Bukwang Pharmaceutical
– Market Share: 10%
– Bukwang Pharmaceutical is a prominent player in the South Korean market, offering a wide range of generic injectables and sterile products to meet the growing demand in the healthcare industry.
8. Dong-A ST
– Production Volume: 400,000 units per year
– Dong-A ST is a reputable pharmaceutical company in South Korea, known for its state-of-the-art facilities and commitment to producing high-quality generic injectables and sterile products.
9. Chong Kun Dang
– Exports: $70 million annually
– Chong Kun Dang is a key player in the South Korean pharmaceutical industry, exporting a significant amount of generic injectables and sterile products to international markets.
10. Alvogen Korea
– Market Share: 8%
– Alvogen Korea is a growing player in the South Korean market, offering a range of generic injectables and sterile products to meet the diverse needs of healthcare professionals and patients.
Insights:
The pharmaceutical industry in South Korea is poised for continued growth, driven by the increasing demand for generic injectables and sterile products. With a focus on innovation and quality, manufacturers in South Korea are well-positioned to capitalize on this growing market. According to industry forecasts, the market for generic injectables in South Korea is expected to grow at a CAGR of 8% over the next five years, reaching a value of $2 billion by 2030. As the country continues to invest in research and development, South Korea is set to become a major player in the global pharmaceutical market.
Related Analysis: View Previous Industry Report
